Credit Suisse Ag Enanta Pharmaceuticals Inc Transaction History

Credit Suisse Ag

$101 Billion
Q1 2024

26 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q3 2023 Nov 13, 2023	SELL	$11.09 - $22.13 $57,401 - $114,544	-5,176 Reduced 15.39%	28,446 $317,000
Q2 2023 Aug 11, 2023	BUY	$20.68 - $39.85 $106,439 - $205,107	5,147 Added 18.08%	33,622 $719,000
Q1 2023 May 10, 2023	BUY	$38.82 - $54.59 $194 - $272	5 Added 0.02%	28,475 $1.15 Million
Q4 2022 Feb 13, 2023	BUY	$40.77 - $53.73 $28,620 - $37,718	702 Added 2.53%	28,470 $1.32 Million
Q3 2022 Nov 10, 2022	BUY	$48.29 - $71.27 $186,061 - $274,603	3,853 Added 16.11%	27,768 $1.44 Million
Q2 2022 Aug 12, 2022	BUY	$38.13 - $76.93 $96,507 - $194,709	2,531 Added 11.84%	23,915 $1.13 Million
Q1 2022 May 16, 2022	SELL	$56.06 - $74.11 $11,043 - $14,599	-197 Reduced 0.91%	21,384 $1.52 Million
Q4 2021 Feb 14, 2022	SELL	$60.19 - $97.37 $47,188 - $76,338	-784 Reduced 3.51%	21,581 $1.61 Million
Q3 2021 Nov 12, 2021	SELL	$41.02 - $58.65 $50,167 - $71,728	-1,223 Reduced 5.18%	22,365 $1.27 Million
Q2 2021 Aug 16, 2021	SELL	$43.76 - $53.11 $57,719 - $70,052	-1,319 Reduced 5.3%	23,588 $1.04 Million
Q1 2021 May 14, 2021	SELL	$41.69 - $54.95 $539,051 - $710,503	-12,930 Reduced 34.17%	24,907 $1.23 Million
Q4 2020 Feb 12, 2021	BUY	$41.16 - $47.47 $119,034 - $137,283	2,892 Added 8.28%	37,837 $1.59 Million
Q3 2020 Nov 13, 2020	BUY	$43.36 - $53.53 $16,736 - $20,662	386 Added 1.12%	34,945 $1.6 Million
Q2 2020 Aug 12, 2020	BUY	$46.37 - $57.58 $941,635 - $1.17 Million	20,307 Added 142.49%	34,559 $1.74 Million
Q1 2020 May 13, 2020	SELL	$40.22 - $62.0 $304,867 - $469,960	-7,580 Reduced 34.72%	14,252 $734,000
Q4 2019 Feb 12, 2020	BUY	$57.95 - $66.61 $123,897 - $142,412	2,138 Added 10.86%	21,832 $1.35 Million
Q3 2019 Nov 12, 2019	SELL	$60.08 - $88.17 $172,609 - $253,312	-2,873 Reduced 12.73%	19,694 $1.18 Million
Q2 2019 Aug 14, 2019	BUY	$81.3 - $97.35 $92,031 - $110,200	1,132 Added 5.28%	22,567 $1.91 Million
Q1 2019 May 14, 2019	SELL	$69.08 - $105.66 $418,970 - $640,827	-6,065 Reduced 22.05%	21,435 $2.05 Million
Q4 2018 Feb 13, 2019	SELL	$65.41 - $84.65 $286,953 - $371,359	-4,387 Reduced 13.76%	27,500 $1.95 Million
Q3 2018 Nov 13, 2018	BUY	$85.46 - $126.37 $106,312 - $157,204	1,244 Added 4.06%	31,887 $2.72 Million
Q2 2018 Aug 14, 2018	BUY	$81.85 - $120.51 $151,340 - $222,822	1,849 Added 6.42%	30,643 $3.55 Million
Q1 2018 May 15, 2018	BUY	$57.91 - $92.15 $12,508 - $19,904	216 Added 0.76%	28,794 $2.33 Million
Q4 2017 Feb 14, 2018	SELL	$45.65 - $59.37 $155,940 - $202,807	-3,416 Reduced 10.68%	28,578 $1.68 Million
Q3 2017 Nov 14, 2017	BUY	$37.91 - $46.8 $126,733 - $156,452	3,343 Added 11.67%	31,994 $1.5 Million
Q2 2017 Aug 14, 2017	BUY	N/A	28,651	28,651 $1.03 Million

Others Institutions Holding ENTA

# of Institutions

110

Shares Held

21.1M

Call Options Held

4.8K

Put Options Held

4.6K

Farallon Capital Management LLC San Francisco, CA

2.11M
Shares

$19.7 Million
0.11% of portfolio
Vanguard Group Inc Valley Forge, PA

1.98M
Shares

$18.5 Million
0.0% of portfolio
Black Rock Inc. New York, NY

1.85M
Shares

$17.3 Million
0.0% of portfolio
Krensavage Asset Management, LLC New York, NY

1.5M
Shares

$14 Million
8.7% of portfolio
Morgan Stanley New York, NY

1.1M
Shares

$10.3 Million
0.0% of portfolio

View Full List

About ENANTA PHARMACEUTICALS INC

Ticker ENTA
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 20,724,900
Market Cap $194M
Description
Enanta Pharmaceuticals, Inc., a biotechnology company, discovers and develops small molecule drugs for the treatment of viral infections and liver diseases. Its research and development disease targets include respiratory syncytial virus, SARS-CoV-2, human metapneumovirus, and hepatitis B virus. The company has a collaborative development and li...

More about ENTA

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Credit Suisse Ag, based on Form 13F filings with the SEC.

News

Stay updated on Credit Suisse Ag with notifications on news.

Account